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NUCLEAR AND CELL MEMBRANE SURFACE AREA 
ALTERATION IN HEXAMETHYLENE BISACETAMIDE (HMBA) 
INDUCED HUMAN COLONIC CARCINOMA CELL LINE (LOVO) 
T.Y.H. Lau, X. Liao'. D.K.Y. Shum*, A.L.M. Cheung, G.L.Tipoe 
Department of Anatomy and Department o f  Biochemis!q*, The University o f  
Hong Kong, Hong Kong. 
The aim of the present study was to determine the effect of HMBA on the 
morphology o f  the nuclear and cell membrane o f  LOVO (CCL-229) using 
electron microscopical and sterwlogical techniques. 2mM and 4mM of HMBA 
were included in the culture medium for a period of 7 days and then for a 
further 3 days HMBA-containing medium was omitted. Control flasks were 
never exposed to HMBA. Cell numbers were counted on days 0,1,3,5,7 and 10 
using a haemocytometer and cells were processed for electron microscopy. 
Inhibition of the growth of CCL-229 cells was produced by 2mM and 4mM 
HMBA treatment during the first 7 days o f  culture but growth resumed after 
HMBA was withdrawn on day 7 and there was an increase in cell number until 
day 10. The nuclear to cytoplasmic ratio (N/C) and surface-to-volume ratio 
(SN)  of the nuclear and plasma membranes were estimated using simple point- 
counting techniques; the nuclear volume (VN) was estimated from point- 
sampled intercepts. From these data cytoplasmic volume ( V C ~ ) ,  cell volume 
("CELL), surface area o f  plasma membrane. (SPWCELL) and nuclear membrane 
(SN") were calculated. Statistical analyses revealed significant increases in 
VCELL and V C ~  with a decrease in N/C in HMBA-treated group on day 7 when 
compared with conhol, but no significant alterations in VN. The values o f  V C ~  
and N/C were maintained up to day 10 despite the absence o f  HMBA. The 
SNNMN significantly decreased in 4mM HMBA-treated cells on day 1 and with 
2mM HMBA-treated group on day 7 when compared with the control. The 
SNPMCE~L also decreased in both HMBA-treated group on day I and in the 
2mM HMBA-treated group on day 3 when compared with the control. 
Generally, SPM.CE~~ progressively decreased in the control group from day 1 to 
day 10 and had lower values when compared with both HMBA-treated groups. 
The SPM,CELL significantly increased in cells treated with 2mM and 4mM 
HMBA on day 7 and persisted till day 10 when codpared with the control 
group. The S N M . ~  increased in the 4mM HMBA-treated group on day 7 when 
compared with the controls. We conclude that HMBA suppresses cell 
proliferation and induces an increase in cell volume and surface area of plasma 
membrane in the later stages o f  the culture period. 
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Effect of material deprivation on Epstein-Barr virus infection in Hodgkin's 
disease: preliminary analysis of a West Midlands population 
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WV1 lDJ, -Department of Histopathology, New Cross Hospital, 
Wolverhampton, WV10 OQP, @Department of Histtpathology, Russells Hall 
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Birmingham. 815 2TT. ADepartment of Histopathology, Birmingham Heartland's 
Hospital, Eordesley Green East, Birmingham. E9 5SS, and 'Institute for Cancer 
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The Epstein-Barr virus (EBV) is detectable in HodgkinlReed-Sternberg (HRS) 
cells in a percentage of Hodgkin's disease (HD) tumours. However, the level of 
EBV-positivity in HD is variable and depends on several factors including age, 
sex and country of residence. In particular. EEV positive HD tumours appear to 
be less common in developed populations. with percentages of between 40-50% 
for North American and European cases, 57% for HD in China, but much higher 
rates in underdeveloped countries such as Peru and Kenya. Although we are 
able to speculate that in the UK. the level of EEV infection in Hodgkin's tumours 
is likely lo be higher in underprivileged populations, data supporting this 
assumption is lacking. 
This study has analysed 123 cases of histologically confirmed Hodgkin's disease 
from the West Midlands, UK, for the presence of EEV in HRS cells using both in 
situ hybridisation to detect the EEERs and immunohistochemistry for the 
demonstration of LMPI. EBV status determined in this way for each patient was 
correlated with Townsend Score which was used as a measure of material 
deprivation. Townsend Scores. between -10 (less deprived) and 10 (most 
deprived), were provided by the West Midlands Cancer Intelligence Unit for 
individual patients based on data from the 1991 OPCS Census. 
261123 patients were identified as EBV-positive. The majority of EEV-positive 
patients (20126) had Townsend scores above zero (indicating higher levels of 
material deprivation), whereas only 56/97 EEV-negative patients had scores 
above zero. Median Townsend scores for EBV-positive and EEV-negative 
groups were 2.3 and 0.5, respectively and the Mann-Whitney test gave a p 
value of 0.34. Similar findings were obtained when the lymphocyte predominant 
andlor the lymphocyte depletion subtype were excluded from the analysis. 
Although these results are not statistically significant they suggest that EBV- 
positive Hodgkin's disease in the West Midlands is more likely in patients from 
materially deprived areas. Further analysis of a larger series of patients is 
required to improve statistical power. 
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Is expression of pZIWAFlICIP1 related to EBV status in Hodgkin's 
disease? 
Christothea Constandinou: Zdenek Kolaf, Jan Martin*, Kenneth Scott-, Stuart 
Haldene-, Eorek Vojtesek", John Crocks?, Lawrence Young'. Paul Murray". 
'School of Health Sciences, University of Wolverhampton, Wolverhampton, 
WV1 IDJ, kentre of Molecular Biology and Medicine, Palacky University, 
Olomouc. Czech Republic, "Masaryk Memorial Cancer Institute, Brno Czech 
Republic, -De artment of Histopathology, New Cross Hospital, Wolverhampton, 
WVlO OQP. Department of Histopathology. Russelis Hall Hospital, Dudley, 
West Midlands, DY1 ZHQ, "West Midlands Cancer Intelligence Unit, The Public 
Health Building. The University of Birmingham, Birmingham, 815 2TT, 
ADepartment of Histopathology, Birmingham Heartland's Hospital, Eordesley 
Green East, Birmingham. B9 5% and 'Institute for Cancer Studies, University 
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pZlWAFl/CIPl (p21) is a nuclear protein inhibitor of several cyclin- 
dependent kinases (cdks). It is a component of the quaternary complexes that 
control the cell cycle and includes cyclin D1, cdks, and the proliferating cell 
nuclear antigen (PCNA). This study has utilised immunohistochemistry to 
analyse the expression of p21 in HodgkinlReed-Sternberg (HRS) cells of 63 
cases of histologically confirmed Hodgkin's disease in relation to Epstein-Barr 
v i m  (EBV) status. EEV status was determined by in situ hybridisation for the 
detection of the EBERs or by immunohistochemistry for LMPI. p21 nUClear 
expression was demonstrated in the majority of cases but intensity of 
expression was variable. High level expression of p21 (>50% HRS cells stained 
or >20% HRS cells strongly stained) was demonstrated in 8/18 EEV-positive 
cases but only in 7/45 EEV-negative tumours. All EEV positive cases showed 
some p21 staining in HRS cells, Four EEV-negative turnours did not express 
detectable levels of p21. An association between high level expression of p21 
and decreased survlval was found in EBV-negative patients. No such trend was 
noted for EBV-positive patients, which may reflect the relatively low numbers of 
patlents in this group. 
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Mapping t(2:5)(p23;q35) Nucleophosmin-Anaplastic Lymphoma 
Kinase Breakpoints in Anaplastic Large Cel l  Lymphoma Cell 
Lines. 
JH Prinnle, JA Shaw, L Potter, L Primrose, A Gillies, P Hickenbotham 
and I Lauder. 
Department o f  Pathology, University o f  Leicester. 
The t(2;5)(p23;q35) translocation fuses the nucleophosmin gene 
(NPM) on chromosome 5q35 to a neuronal protein kinase gene. 
anaplastic lymphoma kinase (ALK) on chromosome 2 ~ 2 3 .  The 
translocation i s  characteristic o f  a sub-group o f  CD3O+ anaplaslic 
large-cell non-Hodgkin's lymphomas (ALCL). Previous studies have 
used long range amplification o f  genomic DNA, isolated from frcsb 
tissue biopsy material, to detect any translocations. We have cloned 
and sequenced the wild type N P M  and A L K  introns and the Karpass 
299 translocation intron and have subsequently mapped the distinct 
intron-specific translocation breakpoints in three A L C L  cell lines (SU- 
DHL-I, SUP-M2 and Karpass 299) by sequence comparison. This has 
enabled the design o f  N P M  and ALK exon and intron-specific primer 
pairs to amplify across the translocation breakpoint in archival tixed 
paraffin-embedded material. The resulting amplified fragments are of 
a size suitable for direct sequencing. 
